All‑cause excess mortality in Germany peaked during the late‑2022 influenza period, exceeding peaks during SARS‑CoV‑2 waves (2020-2023). [PDF]
Heudorf U, Kowall B.
europepmc +1 more source
Identification of Prohibitin (PHB) as an Entry Factor of Highly Pathogenic Coronaviruses Using Metabolic Glycoengineering and Photo-Crosslinking Techniques. [PDF]
Zhu X +13 more
europepmc +1 more source
Extra gene coding capacity of SARS-CoV-2 provides a virus engineering platform for in vitro and in vivo applications. [PDF]
Kim T +5 more
europepmc +1 more source
Editorial: Emergence of Cicada (BA.3.2) SARS-CoV-2 and the Implications for COVID-19 Surveillance and Monitoring. [PDF]
Parums DV.
europepmc +1 more source
SARS-CoV-2 infection in female sex workers from Nairobi, Kenya early in the COVID-19 pandemic: Seroincidence and behavioural associations. [PDF]
Yang SD +6 more
europepmc +1 more source
Inhibitory effects and structural analysis of drug candidate PF-07817883 against coronaviral main proteases (M<sup>pro</sup>) and SARS-CoV-2 M<sup>pro</sup> mutants. [PDF]
Zhao Z +5 more
europepmc +1 more source
SARS-CoV-2 ORF3a suppresses host antiviral interferon responses by promoting STUB1-mediated PTEN proteasomal degradation. [PDF]
Fan L +10 more
europepmc +1 more source
Healthcare professionals' perspectives on usefulness, acceptability and implementation conditions of socially assistive robots in France: a cross-sectional survey and cluster analysis. [PDF]
Blavette L +5 more
europepmc +1 more source

